|
|
| | Hypoglycemic agent 1 Basic information |
| Product Name: | Hypoglycemic agent 1 | | Synonyms: | Hypoglycemic agent 1;Benzeneacetamide, 4-[[1-[2-(1,4-dioxan-2-ylmethoxy)phenyl]pyrrolo[1,2-d][1,2,4]triazin-4-yl]amino]-3-fluoro- | | CAS: | 2253733-57-0 | | MF: | C25H24FN5O4 | | MW: | 477.49 | | EINECS: | | | Product Categories: | | | Mol File: | 2253733-57-0.mol |  |
| | Hypoglycemic agent 1 Chemical Properties |
| density | 1.43±0.1 g/cm3(Predicted) | | pka | 15.95±0.40(Predicted) |
| | Hypoglycemic agent 1 Usage And Synthesis |
| Uses | Hypoglycemic agent 1 acts as a therapeutic and/or prophylactic agent for diabetes. Hypoglycemic agent 1 has an action for lowering blood sugar[1]. | | in vivo | Hypoglycemic agent 1 (Compound 30; 10 mg/kg; orally administered) exhibits the blood glucose lowering rate of 50% in db/db mice[1]. | | References | [1] Heteroaryl amine derivative. WO 2018221433A1. |
| | Hypoglycemic agent 1 Preparation Products And Raw materials |
|